Direct-to-consumer bioidentical hormone replacement therapy with telemedicine
Winona delivers prescription menopause treatments via telemedicine, operating a lean product and marketing-heavy organization (11–50 employees) while scaling global support across six countries. Their tech stack spans Node.js, Python, Go, and PostgreSQL on AWS/Azure/GCP—typical for a consumer health platform—but their project roadmap reveals internal friction: patient onboarding, care workflows, Intercom integration, and lifecycle automation dominate engineering effort, suggesting the company is still building core operational infrastructure rather than optimizing it.
Winona is a direct-to-consumer telehealth company specializing in bioidentical hormone replacement therapy for menopause. Founded in 2020, the company operates from Austin, Texas with a distributed hiring footprint across the Americas, Philippines, and Colombia. The business model combines prescription fulfillment with patient engagement through a customer portal, support systems, and lifecycle marketing campaigns. Recent hiring focus (16 active roles, 5 posted in the last 30 days) skews toward product, marketing, and healthcare roles, reflecting expansion of clinical operations and customer acquisition.
Express.js, Node.js, PostgreSQL, Python, Go, and Java for application logic; AWS, Azure, and GCP for cloud infrastructure; Stripe for payments; Docker and Kubernetes for deployment; Intercom for customer communication.
Winona is actively hiring in the United States, Colombia, Argentina, Paraguay, Uruguay, Brazil, Philippines, and Mexico. Current open roles span product (6), marketing (4), healthcare (2), support (2), and engineering (1).
Core projects include patient portal development, care workflow optimization, Intercom integration, patient onboarding, email/SMS lifecycle campaigns, and internal dashboards and reporting—indicating active scaling of both patient experience and operational infrastructure.
Other companies in the same industry, closest in size